Galectin-3 is a protein from the group of β-galactoside binding lectins with pro-inflammatory properties, presented as a novel biomarker of pathological conditions, such as various types of cancer, especially thyroid cancer [17], acute and chronic heart failure [32,33], chronic pancreatitis [18], prediabetes state and apparent diabetes [34], depression [35], and many others. This evidence concerns the gene LGALS3 and congestive heart failure.